Colin brings over 25 years of global executive experience, including as director of global corporate finance at Arthur Andersen. Over the past 10 years, Colin has been a market leader in the life sciences space, developing and bringing to market new data capture and advanced statistical analytics solutions for pharma and biotech partners undertaking clinical trials. Immediately prior to joining Anju, Colin served as the CEO of Clintara, which led to the company being acquired by Bracket (a Parthenon Capital Partners company), and subsequently joined the senior executive leadership team at Bracket through Bracket’s acquisition by Genstar Capital. Colin drove exponential growth at both companies prior to their acquisitions, generating substantial shareholder returns for both sets of shareholders. Colin received his BA from McGill University and master’s degree in business administration from The University of Chicago.
“I am excited to join a team that has successfully built Anju into one of the fastest-growing life sciences platforms in the market today. I look forward to helping the team continue to grow and lead the market’s adoption of powerful new software solutions and actionable data insights in order to lower costs and increase data aggregation and precision across the life sciences industry,” said Colin Bower.
“Colin brings industry expertise and having built successful business in Clintara and Bracket, he can help commercialize our leading technology platform and actionable data warehouse at Anju,” added Kurien Jacob, CEO, Anju Software Inc.
About Anju Software
Anju Software is a leading provider of comprehensive software and data solutions to the life sciences industry. Anju provides an integrated platform spanning clinical, medical affairs and commercial operations. Anju has combined deep industry and software domain expertise to build a next-generation platform for the life sciences sector that can scale to provide solutions that meet customers’ needs from “molecule to retirement.” Anju solutions are used by large and small pharmaceutical companies, clinical research organizations (CROs), full-service agencies and medical device companies. Data flow between functional areas, seamless communication with third-party systems and AI-based data mining solutions provide a unique way for Anju customers to leverage critical information throughout their ecosystem. For more information, please visit www.anjusoftware.com.
Kurien Jacob | CEO